Behaviour of TEM-1 β-lactamase as a resistance mechanism to ampicillin, mezlocillin and azlocillin in Escherichia coli
Authors:
- 1 February 1986
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Antimicrobial Chemotherapy
- Vol. 17 (2) , 139-146
Abstract
Escherichia coli isolates which synthesised the extremely common ‘TEM-1’ plasmid mediated β-lactamase were more resistant to the α-aminopenicillins, ampicillin, mezlocillin and azlocillin, than were strains which lacked this enzyme. However, many TEM-1+ isolates remained sensitive to therapeutic concentrations of mezlocillin (64 mg/l) to the other α-aminopenicillins. These data suggested that the enzyme afforded weaker protection against mezlocillin than against azlocillin and ampicillin and we attempted to relate this finding to its hydrolytic activity. Extracted TEM-1 β-lactamase hydrolysed high concentrations of mezlocillin more rapidly than ampicillin and azlocillin; however, mezlocillin was calculated to be the weakest substrate at the low concentrations which are likely to be obtainable in the bacterial cell. These data may partly account for the residual activity of mezlocillin against enzyme producers, but target and permeability factors probably also contribute.Keywords
This publication has 1 reference indexed in Scilit:
- Kinetics and significance of the activity of the Sabath and Abrahams's β-lactamase of Pseudomonas aeruginosaagainst cefotaxime and cefsulodingJournal of Antimicrobial Chemotherapy, 1983